The Cry4AaCter tag is a pull-down tag which promotes the formation of inclusion bodies (IBs) that can be resolubilized in an alkaline buffer. Here, we used the Cry4AaCter tag to create a platform for the production of antimicrobial peptides (AMPs) in Escherichia coli featuring a uniform resolubilization process independent of the peptide fused to the pull-down tag. The Cry4AaCter tag conserves the bioactivity of fusion proteins and thus allows the purification of simple AMPs and more complex AMPs stabilized by disulfide bonds. We developed a downstream process (DSP) for the purification of IBs containing the mutated Galleria mellonella insect metalloprotease inhibitor IMPI(I38V), which has a globular structure stabilized by five disulfide b...
Increasing bacterial resistance to antibiotics is a major health concern. The World Health Organizat...
Escherichia coli is a favored host for rapid, scalable expression of recombinant proteins for academ...
Background: Heterologous protein production in Escherichia coli often suffers from bottlenecks such ...
The markets for recombinant proteins are growing and for most applications there is a demand for sol...
The production of recombinant proteins in the microbial host Escherichia coli often results in the f...
A Cry46Ab toxin derived from Bacillus thuringiensis strain TK-E6 shows mosquitocidal activity agains...
Antimicrobial peptides (AMPs) could evolve into new therapeutic lead molecules against multi-resista...
Abstract Background Recombinant protein production and purification from Escherichia coli is often a...
AbstractToday, proteins are typically overexpressed using solubility-enhancing fusion tags that allo...
In recent years, antimicrobial peptides (AMPs) have attracted increasing attention. The microbial ce...
Proteins are now widely produced in diverse microbial cell factories. The Escherichia coli is still ...
Antimicrobial peptides, as a new class of antibiotics, have generated tremendous interest as potenti...
Standard production processes for antimicrobial peptides (amps) comprise of batch cultivations in up...
Commercial uses of bioactive peptides require low cost, effective methods for their production. We d...
Proteins are now widely produced in diverse microbial cell factories. The Escherichia coli is still ...
Increasing bacterial resistance to antibiotics is a major health concern. The World Health Organizat...
Escherichia coli is a favored host for rapid, scalable expression of recombinant proteins for academ...
Background: Heterologous protein production in Escherichia coli often suffers from bottlenecks such ...
The markets for recombinant proteins are growing and for most applications there is a demand for sol...
The production of recombinant proteins in the microbial host Escherichia coli often results in the f...
A Cry46Ab toxin derived from Bacillus thuringiensis strain TK-E6 shows mosquitocidal activity agains...
Antimicrobial peptides (AMPs) could evolve into new therapeutic lead molecules against multi-resista...
Abstract Background Recombinant protein production and purification from Escherichia coli is often a...
AbstractToday, proteins are typically overexpressed using solubility-enhancing fusion tags that allo...
In recent years, antimicrobial peptides (AMPs) have attracted increasing attention. The microbial ce...
Proteins are now widely produced in diverse microbial cell factories. The Escherichia coli is still ...
Antimicrobial peptides, as a new class of antibiotics, have generated tremendous interest as potenti...
Standard production processes for antimicrobial peptides (amps) comprise of batch cultivations in up...
Commercial uses of bioactive peptides require low cost, effective methods for their production. We d...
Proteins are now widely produced in diverse microbial cell factories. The Escherichia coli is still ...
Increasing bacterial resistance to antibiotics is a major health concern. The World Health Organizat...
Escherichia coli is a favored host for rapid, scalable expression of recombinant proteins for academ...
Background: Heterologous protein production in Escherichia coli often suffers from bottlenecks such ...